These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 28733884)
1. Paediatric hepatocellular carcinoma in tight junction protein 2 (TJP2) deficiency. Vij M; Shanmugam NP; Reddy MS; Sankaranarayanan S; Rela M Virchows Arch; 2017 Nov; 471(5):679-683. PubMed ID: 28733884 [No Abstract] [Full Text] [Related]
2. [Progressive familial intrahepatic cholestasis related to mutation of the TJP2 gene: recent advances]. Zhang J; Yu H Zhonghua Gan Zang Bing Za Zhi; 2016 Jan; 24(1):78-80. PubMed ID: 26983395 [TBL] [Abstract][Full Text] [Related]
3. Hepatocellular carcinoma associated with tight-junction protein 2 deficiency. Zhou S; Hertel PM; Finegold MJ; Wang L; Kerkar N; Wang J; Wong LJ; Plon SE; Sambrotta M; Foskett P; Niu Z; Thompson RJ; Knisely AS Hepatology; 2015 Dec; 62(6):1914-6. PubMed ID: 25921221 [No Abstract] [Full Text] [Related]
4. Mutations in TJP2 cause progressive cholestatic liver disease. Sambrotta M; Strautnieks S; Papouli E; Rushton P; Clark BE; Parry DA; Logan CV; Newbury LJ; Kamath BM; Ling S; Grammatikopoulos T; Wagner BE; Magee JC; Sokol RJ; Mieli-Vergani G; ; Smith JD; Johnson CA; McClean P; Simpson MA; Knisely AS; Bull LN; Thompson RJ Nat Genet; 2014 Apr; 46(4):326-8. PubMed ID: 24614073 [TBL] [Abstract][Full Text] [Related]
5. An expanded role for heterozygous mutations of ABCB4, ABCB11, ATP8B1, ABCC2 and TJP2 in intrahepatic cholestasis of pregnancy. Dixon PH; Sambrotta M; Chambers J; Taylor-Harris P; Syngelaki A; Nicolaides K; Knisely AS; Thompson RJ; Williamson C Sci Rep; 2017 Sep; 7(1):11823. PubMed ID: 28924228 [TBL] [Abstract][Full Text] [Related]
6. Novel compound heterozygote mutations of TJP2 in a Chinese child with progressive cholestatic liver disease. Ge T; Zhang X; Xiao Y; Wang Y; Zhang T BMC Med Genet; 2019 Jan; 20(1):18. PubMed ID: 30658709 [TBL] [Abstract][Full Text] [Related]
7. TJP2 hepatobiliary disorders: Novel variants and clinical diversity. Zhang J; Liu LL; Gong JY; Hao CZ; Qiu YL; Lu Y; Feng JY; Li JQ; Li ZD; Wang MX; Xing QH; Knisely AS; Wang JS Hum Mutat; 2020 Feb; 41(2):502-511. PubMed ID: 31696999 [TBL] [Abstract][Full Text] [Related]
8. New tight junction protein 2 variant causing progressive familial intrahepatic cholestasis type 4 in adults: A case report. Wei CS; Becher N; Friis JB; Ott P; Vogel I; Grønbæk H World J Gastroenterol; 2020 Feb; 26(5):550-561. PubMed ID: 32089630 [TBL] [Abstract][Full Text] [Related]
9. The zonula occludens protein family regulates the hepatic barrier system in the murine liver. Itoh M; Terada M; Sugimoto H Biochim Biophys Acta Mol Basis Dis; 2021 Jan; 1867(1):165994. PubMed ID: 33184034 [TBL] [Abstract][Full Text] [Related]
10. Hepatocellular carcinoma in Alagille's syndrome: a family study. Rabinovitz M; Imperial JC; Schade RR; Van Thiel DH J Pediatr Gastroenterol Nutr; 1989 Jan; 8(1):26-30. PubMed ID: 2543804 [TBL] [Abstract][Full Text] [Related]
11. Progressive familial intrahepatic cholestasis type 4 in an Indian child: presentation, initial course and novel compound heterozygous mutation. Mirza N; Bharadwaj R; Malhotra S; Sibal A BMJ Case Rep; 2020 Jul; 13(7):. PubMed ID: 32636225 [TBL] [Abstract][Full Text] [Related]
12. Treatment with an ileal bile acid transporter inhibitor in patients with TJP2 deficiency. Di Giorgio A; Sciveres M; Fuoti M; Sonzogni A; Mandato C; D'Antiga L Clin Res Hepatol Gastroenterol; 2023 Oct; 47(8):102185. PubMed ID: 37499899 [TBL] [Abstract][Full Text] [Related]